JAK3 and acute lymphoblastic leukemia: On the other hand, PHF6 and JAK3 mutations have been confirmed to cooperate and drive T‐ALL progression [16], which is consistent with our study showing PHF6 and JAK3 mutations ranking 1 and 2 individually.